Cellular microRNAs correlate with clinical parameters in multiple injury patients

Diego A Vicente1, Seth A Schobel, Simone Anfossi

  • 1From the Surgical Critical Care Initiative (D.A.V., S.A.S., F.L., V.K., M.J.B., T.G.B., T.A.D., C.J.D., A.D.K., E.A.E.); Department of Surgery (D.A.V., S.A.S., F.L., H.R., V.K., M.J.B., T.A.D., E.A.E.), Uniformed Services University of the Health Sciences; Henry M Jackson Foundation for the Advancement of Military Medicine (S.A.S., F.L., V.K.), Bethesda, Maryland; Translational Molecular Pathology (S.A., M.S., G.A.C.), Houston, Texas; DecisionQ (H.H.), Arlington, Virginia; Department of Surgery (F.L., V.K., M.J.B., E.A.E.), Walter Reed National Military Medical Center, Bethesda, Maryland; Department of Surgery (T.G.B., C.J.D.), Emory University, Atlanta, Georgia; and Department of Surgery (A.D.K.), Duke University, Durham, North Carolina.

Summary

MicroRNAs in polytrauma patients correlate with complicated recoveries. Lower microRNA levels and specific markers like miR-21-3p may predict poor outcomes, offering potential therapeutic targets for immunomodulation.